KLP Kapitalforvaltning AS Buys 6,800 Shares of Alignment Healthcare, Inc. $ALHC

KLP Kapitalforvaltning AS raised its stake in Alignment Healthcare, Inc. (NASDAQ:ALHC) by 39.5% in the second quarter, Holdings Channel reports. The firm owned 24,000 shares of the company’s stock after acquiring an additional 6,800 shares during the quarter. KLP Kapitalforvaltning AS’s holdings in Alignment Healthcare were worth $336,000 as of its most recent SEC filing.

Other hedge funds have also recently bought and sold shares of the company. MCF Advisors LLC grew its stake in Alignment Healthcare by 87.6% in the first quarter. MCF Advisors LLC now owns 2,165 shares of the company’s stock valued at $40,000 after purchasing an additional 1,011 shares in the last quarter. Skandinaviska Enskilda Banken AB publ bought a new position in shares of Alignment Healthcare during the 1st quarter worth approximately $42,000. Amalgamated Bank boosted its stake in shares of Alignment Healthcare by 21.6% during the 1st quarter. Amalgamated Bank now owns 3,466 shares of the company’s stock worth $65,000 after acquiring an additional 616 shares during the period. Signaturefd LLC boosted its stake in shares of Alignment Healthcare by 142.6% during the 2nd quarter. Signaturefd LLC now owns 3,768 shares of the company’s stock worth $53,000 after acquiring an additional 2,215 shares during the period. Finally, Regal Partners Ltd bought a new position in shares of Alignment Healthcare during the 1st quarter worth approximately $194,000. 86.19% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several research analysts have recently commented on the company. Zacks Research upgraded Alignment Healthcare from a “hold” rating to a “strong-buy” rating in a research note on Monday, September 29th. KeyCorp upgraded Alignment Healthcare from a “sector weight” rating to an “overweight” rating and set a $21.00 target price for the company in a research note on Monday, August 25th. The Goldman Sachs Group assumed coverage on Alignment Healthcare in a research note on Tuesday, October 14th. They set a “buy” rating and a $21.00 target price for the company. Wall Street Zen downgraded Alignment Healthcare from a “buy” rating to a “hold” rating in a research note on Sunday, August 10th. Finally, Weiss Ratings reiterated a “sell (d-)” rating on shares of Alignment Healthcare in a research note on Wednesday, October 8th. Two research analysts have rated the stock with a Strong Buy rating, seven have issued a Buy rating, three have given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $19.05.

Alignment Healthcare Stock Performance

NASDAQ:ALHC opened at $17.12 on Monday. The stock has a market cap of $3.39 billion, a P/E ratio of -61.14 and a beta of 1.18. The stock has a 50 day simple moving average of $16.40 and a 200 day simple moving average of $15.60. The company has a current ratio of 1.66, a quick ratio of 1.66 and a debt-to-equity ratio of 2.29. Alignment Healthcare, Inc. has a 1-year low of $10.11 and a 1-year high of $21.06.

Alignment Healthcare (NASDAQ:ALHC) last released its quarterly earnings results on Wednesday, July 30th. The company reported $0.07 earnings per share for the quarter, topping the consensus estimate of ($0.07) by $0.14. The business had revenue of $1.02 billion during the quarter, compared to analysts’ expectations of $960.25 million. Alignment Healthcare had a negative return on equity of 43.68% and a negative net margin of 1.53%.The firm’s revenue for the quarter was up 49.0% compared to the same quarter last year. During the same period last year, the firm posted ($0.13) EPS. Alignment Healthcare has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. Research analysts anticipate that Alignment Healthcare, Inc. will post -0.69 earnings per share for the current year.

Insider Buying and Selling at Alignment Healthcare

In other Alignment Healthcare news, insider Robert L. Scavo sold 29,535 shares of Alignment Healthcare stock in a transaction on Wednesday, September 10th. The stock was sold at an average price of $16.41, for a total value of $484,669.35. Following the completion of the transaction, the insider directly owned 572,555 shares of the company’s stock, valued at $9,395,627.55. The trade was a 4.91% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, President Dawn Christine Maroney sold 215,662 shares of Alignment Healthcare stock in a transaction on Wednesday, September 10th. The shares were sold at an average price of $16.41, for a total value of $3,539,013.42. Following the completion of the transaction, the president directly owned 1,797,237 shares of the company’s stock, valued at $29,492,659.17. This represents a 10.71% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 7,443,207 shares of company stock worth $119,848,080 in the last 90 days. Company insiders own 6.60% of the company’s stock.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.